$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Novel non-reverting salmonella live vaccines 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-039/02
  • C12N-015/00
  • C12N-001/36
  • C12N-001/20
출원번호 US-0675381 (1984-11-27)
발명자 / 주소
  • Stocker Bruce A. D. (Portola Valley CA)
출원인 / 주소
  • Board of Trustees of Leland Stanford Jr. University (Stanford CA 02)
인용정보 피인용 횟수 : 48  인용 특허 : 0

초록

Live vaccines are provided and methods for preparing the live vaccines for protection of a host from a pathogenic microorganism. The vaccines are prepared by introducing at least one modification in a gene involved in at least one, normally at least two, biosynthetic pathways, involving the producti

대표청구항

A method for preparing a live attentuated vaccine from a virulent pathogenic bacterial microorganism, which vaccine has substantially zero probability of reverting to virulence in a vertebrate host, said method comprising: introducing a transposon into a structural gene of a virulent strain of said

이 특허를 인용한 특허 (48)

  1. Briggs Robert E. (Boone IA) Tatum Fred M. (Ames IA), Pasteurella haemolytica PhaI restriction endonuclcape and methyltranstesase.
  2. Briggs Robert E. (Boone IA) Tatum Fred M. (Ames IA), Pasteurella haemolytica transformants.
  3. Lowery, David E.; Fuller, Troy E.; Kennedy, Michael J., Anti-bacterial vaccine compositions.
  4. Lowery,David E.; Fuller,Troy E.; Kennedy,Michael J., Anti-bacterial vaccine compositions.
  5. Lowery, David E.; Fuller, Troy E.; Kennedy, Michael J., Anti-bacterial vaccine compositions with a mutated yleA gene.
  6. Mekalanos John J. ; Klose Karl E., Attenuated auxotrophic microorganisms having a combination of non-attenuating mutations and method for making same.
  7. Lowery, David E.; Fuller, Troy E.; Kennedy, Michael J., Attenuated fhaC mutants of Pasteurellaceae bacteria and vaccine compositions thereof.
  8. Lowery, David E.; Fuller, Troy E.; Kennedy, Michael J., Attenuated yiaO mutants of bacteria.
  9. Dashper, Stuart Geoffrey; Reynolds, Eric Charles; Veith, Paul David; Ang, Ching Seng, Biofilm treatment.
  10. Dashper, Stuart Geoffrey; Reynolds, Eric Charles; Veith, Paul David; Ang, Ching Seng, Biofilm treatment.
  11. Briggs Robert E. ; Tatum Fred M., Construction of Pasteurella haemolytica vaccines.
  12. Briggs Robert E. ; Tatum Fred M., Construction of Pasteurella haemolytica vaccines.
  13. Briggs, Robert E.; Tatum, Fred M., Construction of Pasteurella haemolytica vaccines.
  14. Briggs Robert E. (Boone IA) Tatum Fred M. (Ames IA), DNA encoding pasteurella haemolytica PhaI restriction endonuclease and methyltransterase.
  15. James E. Galen, Expression plasmids.
  16. Dashper, Stuart Geoffrey; Reynolds, Eric Charles; Veith, Paul David; Ang, Ching Seng, Immunology treatment for biofilms.
  17. Evans,Nigel A.; Findly,Robert Craig; Weber,Frederick H., In ovo vaccination against coccidiosis.
  18. Nigel A. Evans ; Robert Craig Findly ; Frederick H. Weber, In ovo vaccination against coccidiosis.
  19. Nigel A. Evans ; Robert Craig Findly ; Frederick H. Weber, In ovo vaccination against coccidiosis.
  20. Coloe Peter John,AUX, Live in ovo vaccine.
  21. Conkle,Harold N.; Schultz,Joseph E.; Blonigen,Scott J.; Weber,Fred H.; Kilanowski,David R.; Monzyk,Bruce; Werner,Timothy M.; Cucksey,Chad M.; McArthur,Hamish A. I.; Tewksbury,Ted L., Method for the purification, recovery, and sporulation of cysts and oocysts.
  22. Conkle,Harold N.; Schultz,Joseph E.; Blonigen,Scott J.; Weber,Fred H.; Kilanowski,David R.; Monzyk,Bruce; Werner,Timothy M.; Cucksey,Chad M.; McArthur,Hamish A. I.; Tewksbury,Ted L., Method for the purification, recovery, and sporulation of cysts and oocysts.
  23. Hutchins, James E.; Tyczkowski, Julius K., Methods for producing oocysts.
  24. Hutchins,James E.; Tyczkowski,Julius K., Methods for producing oocysts.
  25. Morsey Mohamad A.,CAX, Methods for production of recombinant plasmids.
  26. Houng Huo-shu H. ; Warren Richard L., Mutants of Brucella melitensis.
  27. Evans, Nigel A.; Findly, Robert Craig; Weber, Frederick H., Ovo vaccination against coccidiosis.
  28. Reynolds, Eric C.; Slakeski, Nada; Chen, Guang Gao; Barr, George Ian, P. gingivalis antigenic composition.
  29. Reynolds, Eric Charles; Slakeski, Nada; Chen, Chao Guang; Barr, Ian George, P. gingivalis antigenic composition.
  30. Galen, James E., Plasmid maintenance system for antigen delivery.
  31. Galen, James E., Plasmid maintenance system for antigen delivery.
  32. Galen, James E., Plasmid maintenance system for antigen delivery.
  33. Galen, James E.; Vindurampulle, Christofer, Plasmid maintenance system for antigen delivery.
  34. Galen,James E., Plasmid maintenance system for antigen delivery.
  35. Galen,James E., Plasmid maintenance system for antigen delivery.
  36. Galen,James E., Plasmid maintenance system for antigen delivery.
  37. Ross, Bruce C.; Barr, Ian G.; Patterson, Michelle A.; Agius, Catherine T.; Rothel, Linda J.; Margetts, Mai B.; Hocking, Dianna M.; Webb, Elizabeth A., Porphyromonas gingivalis polypeptides and nucleotides.
  38. Ross, Bruce C.; Barr, Ian G.; Patterson, Michelle A.; Agius, Catherine T.; Rothel, Linda J.; Margetts, Mai B.; Hocking, Dianna M.; Webb, Elizabeth A., Porphyromonas gingivalis polypeptides and nucleotides.
  39. Dashper, Stuart Geoffrey; Ang, Ching Seng; Veith, Paul David; Reynolds, Eric Charles, Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease.
  40. Reynolds, Eric Charles; O'Brien Simpson, Neil Martin; Cross, Keith J; Slakeski, Nada, Prevention, treatment and diagnosis of P. gingivalis infection.
  41. Reynolds, Eric Charles; Simpson, Neil Martin O'Brien; Cross, Keith J; Slakeski, Nada, Prevention, treatment and diagnosis of P. gingivalis infection.
  42. Brey Robert N. ; Fulginiti James P. ; Anilionis Algis, Stable purA vectors and uses therefor.
  43. Brey Robert N. ; Fulginiti James P. ; Anilionis Algis, Stable pura vectors and uses therefor.
  44. Reynolds, Eric C.; O'Brien-Simpson, Neil Martin; Slakeski, Nada, Synthetic peptide constructs for the diagnosis and treatment of Periodontitis associated with Porphyromonas gingivalis.
  45. Reynolds, Eric Charles; O'Brien-Simpson, Neil Martin; Slakeski, Nada, Synthetic peptide constructs for the diagnosis and treatment of periodontis associated with Porphyromonas gingivalis .
  46. Dougan Gordon,GBX ; Chatfield Steven Neville,GBX ; Hormaeche Carlos Estenio,GBX, Vaccines containing bacteria attenuated by mutations in two genes of the aromatic amino acid biosynthetic pathway.
  47. Dougan Gordon,GBX ; Chatfield Steven Neville,GBX ; Hormaeche Carlos Estenio,GBX, Vaccines containing salmonella bacteria attenuated by mutations in two genes of the aromatic amino acid biosynthetic pa.
  48. Reynolds,Eric Charles; Slakeski,Nada; Chen,Chao Guang; Barr,Ian George, antigenic composition.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로